Robert J. DiDomenico

Robert J. DiDomenico

Auto-generated profile, based on publicly available information

Robert J. DiDomenico

Department of Pharmacy Practice University of Illinois Chicago Retzky College of Pharmacy Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2005 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
WGWilliam L. Galanter
William L. Galanter
RDRobert J. Didomenico
Robert J. Didomenico
APAudrius Polikaitis
Audrius Polikaitis
Background: Automated clinical decision support has shown promise in reducing medication errors; however, clinicians often do not comply with alerts.

1 March 2014 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
VPValentin Prieto-Centurion
Valentin Prieto-Centurion
MMMichael A. Markos
Michael A. Markos
NRNorma I. Ramey
Norma I. Ramey
HGHélène A. Gussin
Hélène A. Gussin
SNSharmilee M. Nyenhuis
Sharmilee M. Nyenhuis
JKJerry Krishnan
Jerry Krishnan
Rationale: Approximately 20% of patients hospitalized for COPD exacerbations in the United States will be readmitted within 30 days. The Centers for Medicare and Medicaid Services has recently proposed to revise the Hospital Readmissions Reduction Program to financially penalize hospitals with high all-cause 30-day rehospitalization rates after a hospitalization for COPD exacerbation on or after October 1, 2014. Objectives: To report the results of a systematic review of randomized clinical trials evaluating interventions to reduce the rehospitalizations after COPD exacerbations. Methods: Multiple electronic databases were systematically searched to identify relevant studies published between January 1966 and June 2013. Titles, abstracts, and, subsequently, full-text articles were assessed for eligibility. Each study was appraised using predefined criteria. Measurements and Main Results: Among 913 titles and abstracts screened, 5 studies (1,393 participants) met eligibility criteria. All studies had a primary outcome of rehospitalization at 6 or 12 months. No study examined 30-day rehospitalization as the primary outcome. Each study tested a different set of interventions. Two studies (one conducted in Canada and one conducted in Spain and Belgium) showed a decrease in all-cause rehospitalization over 12 months in the intervention group versus comparator group (mean number of hospitalizations per patient, 1.0 vs. 1.8; P = 0.01; percent hospitalized, 45 vs. 67%; P = 0.028; respectively). The only study conducted in the United States found a greater than twofold higher risk of mortality in the intervention group (17 vs. 7%, P = 0.003) but no significant difference in rehospitalizations. It was unclear which set of interventions was effective or harmful. Conclusions: The evidence base is inadequate to recommend specific interventions to reduce rehospitalizations in this population and does not justify penalizing hospitals for high 30-day rehospitalization rates after COPD exacerbations.

1 January 2006 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
JBJerry L. Bauman
Jerry L. Bauman
RDRobert J. DiDomenico
Robert J. DiDomenico
WGWilliam L. Galanter
William L. Galanter

13 February 2020 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
BMBrianna McQuade
Brianna McQuade
BRBrent N. Reed
Brent N. Reed
RDRobert J. DiDomenico
Robert J. DiDomenico
WBWilliam L. Baker
William L. Baker
ASAndrea G. Shipper
Andrea G. Shipper
JJJennie Jarrett
Jennie Jarrett

1 April 2004 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
RDRobert J DiDomenico
Robert J DiDomenico
HPHayley Y Park
Hayley Y Park
MSMary Ross Southworth
Mary Ross Southworth
HEHeather M Eyrich
Heather M Eyrich
RLRichard K Lewis
Richard K Lewis
GSGlen T Schumock
Glen T Schumock
OBJECTIVE To describe the development of guidelines for the treatment of acute decompensated heart failure (ADHF) in the emergency department/observation unit (ED-OU) setting for hospitals that are part of a group purchasing organization (GPO). DATA SOURCES A MEDLINE search (1966-March 2003) using the following search terms: cardiotonic agents; diuretic; dobutamine; heart failure, congestive; milrinone; natriuretic peptide, brain; nesiritide; nitroglycerin; vasodilator agents, was conducted. STUDY SELECTION AND DATA EXTRACTION Relevant articles in the English language were identified. All randomized studies and meta-analyses for each category of drugs were included. DATA SYNTHESIS A group consensus method was used to develop guidelines. An expert panel reviewed and revised the guidelines. The final guidelines were approved June 1, 2003, and are described here. They are organized based upon a patient's symptomatology at the time the diagnosis of ADHF is made. Patients with evidence of volume overload require intravenous diuretics and/or intravenous vasodilators to alleviate the symptoms of ADHF. Patients with signs and symptoms of low cardiac output require inotropic support to manage their ADHF. A timeline for diagnosis, treatment, reassessment, and disposition is provided and encourages an early, aggressive approach to treating patients with ADHF. CONCLUSIONS Hospitalization for ADHF is common and costly. Consensus guidelines for the treatment of ADHF did not previously exist, resulting in inconsistent and inefficient treatment. Consequently, hospitals struggling with the treatment of ADHF may find these guidelines and the process by which they were developed useful. THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT ACPE UNIVERSAL PROGRAM NUMBER: 407-000-04-015-H01

1 May 2013 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
SMSherry K. Milfred-LaForest
Sherry K. Milfred-LaForest
SCSheryl L. Chow
Sheryl L. Chow
RDRobert J. DiDomenico
Robert J. DiDomenico
KDKathleen Dracup
Kathleen Dracup
CEChristopher R. Ensor
Christopher R. Ensor
BMBarry M. Massie
Barry M. Massie